Zymeworks
ZYME
139 hedge funds and large institutions have $396M invested in Zymeworks in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 49 increasing their positions, 39 reducing their positions, and 19 closing their positions.
26% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 39
16% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 19
1% more funds holding
Funds holding: 137 → 139 (+2)
6.94% less ownership
Funds ownership: 98.83% → 91.89% (-6.9%)
12% less call options, than puts
Call options by funds: $607K | Put options by funds: $688K
28% less capital invested
Capital invested by funds: $548M → $396M (-$152M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$5.38M |
| 2 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$3.16M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.44M |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$2.17M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$7.39M |
| 2 |
PA
Perceptive Advisors
New York
|
-$7.16M |
| 3 |
BNP Paribas Asset Management
Paris,
France
|
-$4.55M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.62M |
| 5 |
Renaissance Technologies
New York
|
-$1.82M |
ZYME Hedge Fund Activity: Q3 2023 in Review
139 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q3 2023, worth a combined $396M — down 28% from $548M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new ZYME positions and 19 closed out — a net gain of 3 holders — while 49 added to existing stakes and 39 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $5.38M. The largest seller was Morgan Stanley, cutting an estimated $7.39M.
- 139 institutional investors held Zymeworks (ZYME) as of Q3 2023, up from 137 in Q2 2023.
- Funds reported $396M of Zymeworks stock for Q3 2023, down 28% quarter-over-quarter.
- 22 funds opened new Zymeworks positions in Q3 2023 and 19 closed out, a net change of +3 holders.
- The largest Zymeworks buyer in Q3 2023 was Acadian Asset Management, an estimated $5.38M added.
- The largest Zymeworks seller in Q3 2023 was Morgan Stanley, an estimated $7.39M sold.
Based on aggregated 13F filings for Q3 2023.